BALTIMORE, Oct. 10 /PRNewswire/ -- A nationally recognized faculty will present the very latest treatment strategies for patients with breast cancer in the multimedia course "Optimizing Adjuvant Breast Cancer Strategies: From Biomarkers to Treatment Selection" during National Breast Cancer Awareness Month.
It is challenging for practicing oncologists and other interested
health care providers to stay up to date on the latest patient care
advances. This accredited course offers concise, expert reporting on key,
practical treatment innovations, including research from recent American
Society of Clinical Oncology (ASCO) annual meetings and San Antonio Breast
-- Program Chair Antonio C. Wolff, MD, FACP, of the Johns Hopkins Sidney
Kimmel Comprehensive Cancer Center, will discuss biomarkers.
-- Harold J. Burstein, MD, PhD, from the Breast Oncology Center, the
Dana-Farber Cancer Institute, and Harvard Medical School, will present
on recent developments in chemotherapy-biologic treatments.
-- Ana Maria Gonzalez-Angulo, MD, MSc, of The University of Texas M. D.
Anderson Cancer Center, will discuss the issue anthracycline related
Physicians can register for and take this accredited, virtual e-conference course at any time beginning Tuesday, October 14, 2008 at http://www.virtualbreastcancer.com. Participants learn at their own pace and utilize interactive case studies, choosing treatments for simulated patients, and receiving feedback on their decisions.
As a bonus, the faculty will offer a "Live Question-and-Answer Session" on October 14, 2008, from noon to 2:00pm (EDT). The course, including faculty presentations and questions and answers generated on October 14, will remain available for one year.
The course is presented by The Johns Hopkins University School of Medicine in cooperation with PharmacoMedia LLC, and is supported by an educational grant from sanofi-aventis U.S. It is available at no cost to participants.
|SOURCE PharmacoMedia LLC|
Copyright©2008 PR Newswire.
All rights reserved